ASVIPANTO-40 is a sterile lyophilized injectable of Pantoprazole Sodium IP that contains Pantoprazole 40mg. It belongs to the class of proton pump inhibitors (PPIs), which lower the amount of acid secreted in the stomach by blocking the acid-secreting system in the stomach lining. This intravenous preparation is aimed at hospital or clinical practice situations, where quick action of acid suppression is needed, particularly where oral treatment becomes impractical. The presence of mannitol is important to provide stability and proper reconstitution. ASVIPANTO-40 is good in managing the disorders caused by acid and assists in the maintenance of the gastrointestinal tract against excessive acid.
Medical Uses
ASVIPANTO-40 is used for gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and prevention of stress ulcers among patients with critical conditions. It is also applied to patients who cannot take oral medications because of surgery or serious diseases, such as upper gastrointestinal bleeding. It reduces the secretion of acids, thus accelerating the healing of damaged mucosa, and decreases irritation and discomfort that comes with hyperacidity.
Directions to Use
It should only be taken if a qualified medical practitioner administers such an injection. The lyophilized product should be resettled using the suggested diluent and administered intravenously as per the prescribed dosage and infusion guidelines. Dose and duration are decided based on the condition of the patient, the severity of the symptoms, and the way the patient responds to it. Self-administration should be avoided. Medical directions should be followed by the patients, and they should inform the physician about any unusual symptoms that develop in some cases.
Precautions
Before initiating ASVIPANTO-40, report past presence of liver disorders, allergies to PPIs, or if you are currently taking medications. Magnesium and vitamin B12 levels and status should be monitored after long-term use. It is contraindicated in patients with difficult hepatic impairment and advanced age. Use of this medicine in either pregnancy or breastfeeding should be done under the express necessity and should be prescribed by a physician.
Possible Side Effects
There are chances that some patients might have a headache, nausea, diarrhea, abdominal pain, or a reaction to injection site. Dizziness, rash, and electrolyte imbalance may rarely occur. The complexity of the side effects is mostly minor and temporary, although medical consultations should be pursued when the symptoms do not fade away as time goes by or become worse.
FAQs
Q: Is it possible to use ASVIPANTO-40 when it comes to emergency acid suppression?
A: Yes, it is frequently used in hospitals when acid needs to be controlled quickly, when gastric defense is needed, such as in cases of acute bleeding or severe reflux.
Q: What does Asvins Lifecare do to guaranteethe quality of the product of ASVIPANTO-40?
A: The company adheres to rigorous manufacturing procedures, quality assurance testing, and commitment to safety, sterility, and uniformity of therapeutic behavior between batches.
Q: Does Asvipanto-40 injectable therapy necessitate monitoring in case of long-term treatment?
A: Physicians can monitor electrolytes, liver activities, and general response to be sure they are safe using it, especially where the use goes beyond short-term treatment.
Q: Who is the usual physician to use ASVIPANTO-40 in clinical practice?
A: It is given intravenously by trained medical workers, nurses, or physicians with medical attendance to guarantee the optimal dosing and oversight.
Q: Does ASVIPANTO-40 have a place in the post-surgical acid control?
A: It is commonly administered postoperatively to decrease the amount of acid secreted and minimise the chances of mucosal damage caused by stress during the recovery period.
